was diluted in THF (3 mL) and cooled to −78 ◦C under N2 atm. A
solution of diazomethane in Et2O was added dropwise until TLC
showed no starting material. N2 was bubbled into the mixture for
30 min to remove the unreacted diazomethane and the solvent was
then evaporated under reduced pressure. Column chromatography
(CH2Cl2–pentane, 60 : 40) afforded 1 as a yellow oil (0.181 g, 57%
over two steps from the dienol 15). 1H NMR (300 MHz, CDCl3):
d 7.14–7.3 (m, 10H), 6.24 (s, 2H), 6.10–6.30 (m, 2H), 5.65 (ddd,
J = 14.4, 6.9, 6.9 Hz, 1H), 5.01 (dd, J = 14.4, 9.9 Hz, 1H), 4.65
(d, J = 6.9 Hz, 2H), 3.76 (s, 3H), 2.25–2.33 (m, 1H), 1.68 (dd, J =
8.4, 4.8 Hz, 1H), 1.53 (dd, J = 5.4, 4.8 Hz, 1H) ppm. 13C NMR
(75 MHz, CDCl3): d 166.0, 165.2, 146.5, 141.4, 137.6, 135.5, 131.1,
130.1, 130.0, 128.8, 128.7, 128.6, 127.5, 127.0, 126.3, 123.2, 66.0,
52.4, 38.2, 30.9, 23.7 ppm. IR (thin film): mmax 3057, 3025, 2951,
1730, 1650, 1495, 1437, 1391, 1212, 1162 cm−1. EIMS: m/z (%):
388 (M+, 35), 357 (38), 342 (46), 329 (28), 328 (100). HRMS: calcd
for C25H24O4: 388.1675; found 388.1678.
Methyl (2E,4E)-5-(2,2-diphenylcyclopropyl)penta-2,4-dienyl
fumarate (2)
To a solution of 15 (1.674 g, 6.06 mmol, 1 equiv.) in CH2Cl2
(50 mL) at 0 ◦C under N2 atm were added pyridine (1.18 mL,
14.54 mmol, 2.4 equiv.) and 4-dimethylaminopyridine (74 mg,
0.606 mmol, 0.1 equiv.). (E)-Methyl 3-(chlorocarbonyl)acrylate
(1.08 g, 7.27 mmol, 1.2 equiv.) was then added dropwise at
0
◦C. The reaction was stirred at this temperature for 10 min
then allowed to warm to rt. After 1.5 h, water was added. The
organic phase was then collected and washed with 1 M aqueous
HCl, saturated NaHCO3 and brine. The organic layer was dried
(MgSO4) and concentrated in vacuo. Column chromatography
(petroleum ether 40–60–ethyl acetate, 95 : 5) afforded 2 as a yellow
1
oil (1.22 g, 52%). H NMR (300 MHz, CDCl3): d 7.12–7.36 (m,
10H), 6.86 (s, 2H), 6.10–6.29 (m, 2H), 5.65 (ddd, J = 14.5, 6.9,
6.9 Hz, 1H), 5.02 (dd, J = 14.5, 9.7 Hz, 1H), 4.66 (d, J = 6.9 Hz,
2H), 3.80 (s, 3H), 2.25–2.33 (m, 1H), 1.67 (dd, J = 8.7, 4.8 Hz,
1H), 1.53 (dd, J = 5.7, 4.8 Hz, 1H) ppm. 13C NMR (75 MHz,
CDCl3): d 165.6, 164.9, 146.5, 141.3, 137.8, 135.5, 133.9, 133.6,
131.0, 128.7, 128.6, 128.5, 127.5, 126.9, 126.2, 122.9, 66.1, 52.6,
38.2, 30.8, 23.1 ppm. IR (thin film): mmax 3058, 3025, 2951, 1723,
1652, 1495, 1445, 1301, 1259, 1153, 986 cm−1. EIMS: m/z (%): 388
(M+, 7), 259 (42), 258 (96), 217 (50), 206 (54), 205 (56), 191 (75),
167 (100). HRMS: calcd for C25H24O4: 388.1675; found 388.1673.
rel-(3aR,4S,5S,7aS,1ꢀR)-Methyl 1,3,3a,4,5,7a-hexahydro-3-oxo-
5-(2,2-diphenylcyclopropyl)isobenzofuran-4-carboxylate (17a) and
rel-(3aR,4R,5S,7aS,1ꢀR)-methyl 1,3,3a,4,5,7a-hexahydro-3-oxo-
5-(2,2-diphenylcyclopropyl)isobenzofuran-4-carboxylate (19a)
A solution of 1 (0.457 g, 1.17 mmol, 1 equiv.) and 2,6-di-tert-butyl-
4-methylphenol (3 mg, 14 lmol, 0.01 equiv.) in toluene (250 mL)
was heated at reflux under N2 atm for 5 h. The solvent was then
evaporated under reduced pressure and 1H NMR analysis revealed
the presence of two cycloadducts. The two adducts 17a and 19a
were isolated by column chromatography (petroleum ether 40–60–
ethyl acetate–triethylamine, 96 : 2 : 2) in a ratio of 82 : 18 (340.9 mg,
75% combined yield).
rel-(3aR,4R,5S,7aS,1ꢀR)-Methyl 1,3,3a,4,5,7a-hexahydro-3-oxo-
5-(2,2-diphenylcyclopropyl)isobenzofuran-4-carboxylate (17b) and
rel-(3aS,4S,5R,7aR,1ꢀR)-methyl 1,3,3a,4,5,7a-hexahydro-3-oxo-
5-(2,2-diphenylcyclopropyl)isobenzofuran-4-carboxylate (18b)
A solution of 2 (0.244 g, 0.63 mmol, 1 equiv.) and 2,6-di-tert-
butyl-4-methylphenol (2 mg, 9 lmol, 0.01 equiv.) in chlorobenzene
(125 mL) was heated to reflux under N2 atm for 12 h. The solvent
was then removed under reduced pressure and 1H NMR analysis
of the crude mixture revealed the presence of two cycloadducts.
The two adducts 17b and 18b were isolated from a fraction of the
crude mixture by column chromatography (petroleum ether 40–
60–ethyl acetate, 98 : 2, with 2% triethylamine) in a ratio of 86 : 14
(154.2 mg, 63% combined yield).
17a. White solid (279.5 mg, 61%): mp 161 ◦C. 1H NMR
(300 MHz, CDCl3): d 7.08–7.28 (m, 10H), 5.71 (ddd, J = 9.9,
1.5, 1.5 Hz, 1H), 5.67 (ddd, J = 9.9, 3.0, 3.0 Hz, 1H), 4.47 (dd,
J = 14.5, 7.5 Hz, 1H), 3.86 (dd, J = 11.5, 7.5 Hz, 1H), 3.55 (s,
3H), 3.27 (d, J = 3.6 Hz, 1H), 3.09–3.14 (m, 1H), 2.44 (dd, J =
13.6, 3.6 Hz, 1H), 1.88 (d, J = 10.5, 1H), 1.65–1.74 (m, 1H), 1.55
(dd, J = 5.4, 5.1 Hz, 1H), 1.13 (dd, J = 8.7, 5.1 Hz, 1H) ppm. 13
C
NMR (75 MHz, CDCl3): d 175.0, 172.3, 146.4, 140.7, 132.5, 129.9,
129.1, 128.8, 128.6, 126.9, 126.6, 123.9, 70.9, 52.4, 42.6, 42.3, 39.9,
38.7, 36.6, 32.2, 18.5 ppm. IR (KBr disc): mmax 2917, 1785, 1732,
1495, 1445, 1379, 1177, 1090 cm−1. EIMS: m/z (%): 388 (M+, 12),
357 (27), 356 (5), 330 (11), 329 (24), 328 (100). Anal. Calcd for
C25H24O4: C, 77.30; H, 6.23. Found: C, 77.34; H, 6.25. HRMS:
calcd for C25H24O4: 388.1675; found 388.1672.
17b. White solid (132.6 mg, 54%): mp 188–189 ◦C. 1H NMR
(300 MHz, CDCl3): d 7.10–7.20 (m, 10H), 5.71 (ddd, J = 9.9, 1.6,
1.6 Hz, 1H), 5.62 (ddd, J = 9.9, 3.0, 3.0 Hz, 1H), 4.39 (dd, J = 8.1,
6.3 Hz, 1H), 3.92 (dd, J = 11.1, 8.1 Hz, 1H), 3.73 (s, 3H), 2.83 (dd,
J = 11.4, 7.5 Hz, 1H), 2.70 (dd, J = 13.5, 11.4 Hz, 1H), 2.60–2.71
(m, 1H), 1.85–1.95 (m, 1H), 1.61–1.71 (m, 1H), 1.42–1.50 (m, 1H),
1.02 (dd, J = 8.5, 5.2 Hz, 1H) ppm. 13C NMR (75 MHz, CDCl3): d
174.5, 171.6, 146.4, 140.5, 133.3, 129.7, 129.6, 128.6, 128.4, 126.8,
126.7, 123.2, 70.5, 52.1, 43.6, 42.1, 40.9, 38.3, 35.8, 28.6, 18.5 ppm.
IR (KBr disc): mmax 2950, 2918, 2849, 1787, 1738, 1494, 1445, 1321,
1273, 1178, 1087. EIMS: m/z (%): 388 (M+, 11), 258 (14), 220 (16),
217 (9), 194 (68), 193 (100). HRMS: calcd for C25H24O4: 388.1675;
found 388.1674.
◦
1
19a. White solid (61.4 mg, 14%): mp 159–160 C. H NMR
(300 MHz, CDCl3): d 7.07–7.26 (m, 10H), 5.92 (ddd, J = 9.9, 2.7,
2.7 Hz, 1H), 5.59 (ddd, J = 9.9, 2.7, 2.7 Hz, 1H), 4.40 (dd, J =
8.7, 8.7 Hz, 1H), 4.10 (dd, J = 8.4, 8.4 Hz, 1H), 3.61 (s, 3H), 3.14
(dd, J = 5.8, 5.8 Hz, 1H), 2.97–3.00 (m, 1H), 2.88 (dd, J = 10.6,
5.8 Hz, 1H), 1.61–1.68 (m, 1H), 1.50–1.58 (m, 1H), 1.38 (dd, J =
5.4, 5.4 Hz, 1H), 1.24 (dd, J = 8.6, 5.4 Hz, 1H) ppm. 13C NMR
(75 MHz, CDCl3): d 175.1, 171.6, 146.3, 140.5, 133.3, 130.6, 129.7,
128.7, 128.6, 128.4, 126.7, 123.1, 70.5, 52.1, 43.5, 42.1, 40.9, 38.3,
35.4, 28.6, 18.5 ppm. IR (KBr disc): mmax 3025, 2923, 1765, 1730,
1494, 1445, 1385, 1173, 1019 cm−1. EIMS: m/z (%): 388 (M+, 23),
357 (38), 339 (12), 198 (10), 197 (59), 194 (77), 193 (100). HRMS:
calcd for C25H24O4: 388.1675; found 388.1676.
◦
1
18b. White solid (21.6 mg, 9%): mp 185–187 C. H NMR
(300 MHz, CDCl3): d 7.04–7.27 (m, 10H), 5.82 (ddd, J = 9.6, 2.1,
2.1 Hz, 1H), 5.72 (ddd, J = 9.6, 2.8, 2.8 Hz, 1H), 4.38 (dd, J = 8.2,
6.6 Hz, 1H), 3.90 (dd, J = 11.1, 8.2, 1H), 3.51 (s, 3H), 2.86 (dd, J =
11.1, 7.8 Hz, 1H), 2.72 (dd, J = 13.5, 11.1 Hz, 1H), 2.48–2.66 (m,
2614 | Org. Biomol. Chem., 2007, 5, 2606–2616
This journal is
The Royal Society of Chemistry 2007
©